In Frontiers in bioinformatics
The rapid and accurate in silico prediction of protein-ligand binding free energies or binding affinities has the potential to transform drug discovery. In recent years, there has been a rapid growth of interest in deep learning methods for the prediction of protein-ligand binding affinities based on the structural information of protein-ligand complexes. These structure-based scoring functions often obtain better results than classical scoring functions when applied within their applicability domain. Here we review structure-based scoring functions for binding affinity prediction based on deep learning, focussing on different types of architectures, featurization strategies, data sets, methods for training and evaluation, and the role of explainable artificial intelligence in building useful models for real drug-discovery applications.
Meli Rocco, Morris Garrett M, Biggin Philip C
2022-Jun-17
binding affinity, deep learning, docking, in silico drug discovery, machine learning, protein-ligand binding, scoring functions, structure-based drug discovery
